Skip to main content

Table 2 Analysis of associations between CFS risk and mtDNA major haplogroups

From: Mitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome

Haplogroup

Case

Control

p value

q value*

Odds ratio

95 % CI

A

2

4

0.69

0.98

0.50

0.05 < OR < 3.56

B

2

2

1.00

1

1.02

0.07 < OR < 14.14

C

0

3

0.25

0.98

–

–

D

0

1

1.00

1

–

–

F

0

1

1.00

1

–

–

G

0

1

1.00

1

–

–

H

81

70

0.21

0.98

1.30

0.85 < OR < 2.00

I

4

7

0.54

0.98

0.57

0.12 < OR < 2.29

J

12

10

0.67

0.98

1.23

0.47 < OR < 3.27

K

20

15

0.38

0.98

1.39

0.65 < OR < 3.03

L

6

11

0.32

0.98

0.54

0.16 < OR < 1.63

M

2

1

0.62

0.98

2.04

0.11 < OR < 120.99

N

2

1

0.62

0.98

2.04

0.11 < OR < 120.99

R

1

0

0.50

0.98

–

–

T

14

28

0.03

0.6

0.47

0.22 < OR < 0.96

U

28

31

0.78

1

0.90

0.50 < OR < 1.63

V

6

3

0.33

0.98

2.06

0.43 < OR < 12.92

W

2

2

1.00

1

1.02

0.07 < OR < 14.14

X

4

2

0.45

0.98

2.05

0.29 < OR < 22.90

HV

7

3

0.22

0.98

2.42

0.54 < OR < 14.69

  1. *q values were calculated using the Benjamini–Hochberg method for correcting for multiple testing of haplogroups